Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic Review.

Bolotin S, Hughes SL, Gul N, Khan S, Rota PA, Severini A, Hahné S, Tricco A, Moss WJ, Orenstein W, Turner N, Durrheim D, Heffernan JM, Crowcroft N.

J Infect Dis. 2019 Nov 1. pii: jiz380. doi: 10.1093/infdis/jiz380. [Epub ahead of print]

PMID:
31674648
2.

Exploring indirect protection associated with influenza immunization - A systematic review of the literature.

Friedman L, Renaud A, Hines D, Winter A, Bolotin S, Johnstone J, Kwong JC, McGeer AJ, Crowcroft NS, Warshawsky BF.

Vaccine. 2019 Nov 20;37(49):7213-7232. doi: 10.1016/j.vaccine.2019.09.086. Epub 2019 Oct 22. Review.

3.

Evaluating the use of whole genome sequencing for the investigation of a large mumps outbreak in Ontario, Canada.

Stapleton PJ, Eshaghi A, Seo CY, Wilson S, Harris T, Deeks SL, Bolotin S, Goneau LW, Gubbay JB, Patel SN.

Sci Rep. 2019 Aug 30;9(1):12615. doi: 10.1038/s41598-019-47740-1.

4.

Letter to the editor: Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections.

Bolotin S, Crowcroft NS, Hughes SL, De Serres G.

Euro Surveill. 2019 Jul;24(30). doi: 10.2807/1560-7917.ES.2019.24.30.1900465. No abstract available.

5.

Measles outbreaks demand systems-level action locally, nationally and globally.

Crowcroft NS, Bolotin S.

CMAJ. 2019 Jul 15;191(28):E777-E778. doi: 10.1503/cmaj.190559. No abstract available.

PMID:
31308005
6.

The evolving nature of Bordetella pertussis in Ontario, Canada, 2009-2017: strains with shifting genotypes and pertactin deficiency.

Tsang RSW, Shuel M, Cronin K, Deng S, Whyte K, Marchand-Austin A, Ma J, Bolotin S, Crowcroft N, Schwartz K, Van Domselaar G, Graham M, Jamieson FB.

Can J Microbiol. 2019 Nov;65(11):823-830. doi: 10.1139/cjm-2019-0128. Epub 2019 Jul 11.

PMID:
31295416
7.

Asymptomatic infection and transmission of pertussis in households: a systematic review.

Craig R, Kunkel E, Crowcroft NS, Fitzpatrick MC, de Melker H, Althouse BM, Merkel T, Scarpino SV, Koelle K, Friedman L, Arnold C, Bolotin S.

Clin Infect Dis. 2019 Jun 29. pii: ciz531. doi: 10.1093/cid/ciz531. [Epub ahead of print]

PMID:
31257450
8.

Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.

Bolotin S, Severini A, Hatchette T, McLachlan E, Savage R, Hughes SL, Wang J, Deeks SL, Wilson S, Brisson M, Halperin SA, Gubbay J, Mazzulli T, Serhir B, Ward BJ, Crowcroft N.

Hum Vaccin Immunother. 2019 Jul 16:1-9. doi: 10.1080/21645515.2019.1619402. [Epub ahead of print]

PMID:
31184979
9.

Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus by Use of the BioPlex 2200.

McLachlan E, Scholz H, Bolotin S, Crowcroft NS, Hatchette TF, Jackson C, Severini A; Immunity of Canadians and Risk of Epidemics (iCARE) Laboratory Group and the Canadian Immunization Research Network (CIRN).

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00296-19. doi: 10.1128/JCM.00296-19. Print 2019 Aug.

10.

Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015.

Crowcroft NS, Schwartz KL, Chen C, Johnson C, Li Y, Marchand-Austin A, Bolotin S, Jamieson FB, Drews SJ, Russell ML, Svenson LW, Simmonds K, Mahmud SM, Kwong JC.

Vaccine. 2019 May 1;37(19):2617-2623. doi: 10.1016/j.vaccine.2019.02.047. Epub 2019 Apr 6.

11.

Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.

Wilson SE, Rosella LC, Wang J, Renaud A, Le Saux N, Crowcroft NS, Desai S, Harris T, Bolotin S, Gubbay J, Deeks SL.

Vaccine. 2019 Apr 17;37(17):2408-2414. doi: 10.1016/j.vaccine.2019.01.061. Epub 2019 Feb 11.

12.

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

van Tilborg M, Al Marzooqi SH, Wong WWL, Maan R, Vermehren J, Maasoumy B, Mazzulli T, Bolotin S, Garber G, Guerra F, Flud CR, Kowgier M, Janssen HL, de Knegt RJ, Pawlotsky JM, Cloherty GA, Duarte-Rojo A, Sarrazin C, Wedemeyer H, Feld JJ.

Lancet Gastroenterol Hepatol. 2018 Dec;3(12):856-864. doi: 10.1016/S2468-1253(18)30271-1. Epub 2018 Sep 28.

PMID:
30274834
13.

Assessing the severity of influenza: a role for longitudinal telephone surveys?

Pebody RG, Boddington NL, Green HK, Bolotin S, Charlett A, Watson JM.

Epidemiol Infect. 2018 Dec;146(16):2042-2048. doi: 10.1017/S0950268818002261. Epub 2018 Aug 15.

14.

Under-reporting of pertussis in Ontario: A Canadian Immunization Research Network (CIRN) study using capture-recapture.

Crowcroft NS, Johnson C, Chen C, Li Y, Marchand-Austin A, Bolotin S, Schwartz K, Deeks SL, Jamieson F, Drews S, Russell ML, Svenson LW, Simmonds K, Mahmud SM, Kwong JC.

PLoS One. 2018 May 2;13(5):e0195984. doi: 10.1371/journal.pone.0195984. eCollection 2018.

15.

Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.

Guerra FM, Crowcroft NS, Friedman L, Deeks SL, Halperin SA, Severini A, Hatchette TF, Bolotin S; Immunity of Canadians and Risk of Epidemics (iCARE) Network.

Vaccine. 2018 Feb 28;36(10):1248-1255. doi: 10.1016/j.vaccine.2018.01.002. Epub 2018 Feb 2. Review.

PMID:
29398276
16.

Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.

Bolotin S, Feld JJ, Garber G, Wong WWL, Guerra FM, Mazzulli T.

PLoS One. 2018 Jan 23;13(1):e0191184. doi: 10.1371/journal.pone.0191184. eCollection 2018.

17.

Case-control study of household contacts to examine immunological protection from Bordetella pertussis transmission - study protocol.

Bolotin S, Johnson C, Quach S, Ambrose A, DeCoutere S, Deeks SL, Drews S, Faheem A, Green K, Halperin SA, Hoang L, Jamieson F, Kollmann T, Marchand-Austin A, McCormack D, McGeer A, Murti M, Bba AO, Rebbapragada A, Vanderkooi OG, Wang J, Warshawsky B, Crowcroft NS; Canadian Immunization Research Network Provincial Collaborative Network.

CMAJ Open. 2017 Dec 19;5(4):E872-E877. doi: 10.9778/cmajo.20170072.

18.

The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014.

Bolotin S, Lim G, Dang V, Crowcroft N, Gubbay J, Mazzulli T, Schabas R.

PLoS One. 2017 Aug 29;12(8):e0181172. doi: 10.1371/journal.pone.0181172. eCollection 2017.

19.

The basic reproduction number (R0) of measles: a systematic review.

Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, Crowcroft NS.

Lancet Infect Dis. 2017 Dec;17(12):e420-e428. doi: 10.1016/S1473-3099(17)30307-9. Epub 2017 Jul 27. Review.

PMID:
28757186
20.

Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada.

Rivera LA, Li Y, Savage RD, Crowcroft NS, Bolotin S, Rosella LC, Lou W, Hopkins J, Gemmill I, Johnson I.

BMC Public Health. 2017 Feb 15;17(1):199. doi: 10.1186/s12889-017-4073-6.

21.

Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.

Hatchette TF, Scholz H, Bolotin S, Crowcroft NS, Jackson C, McLachlan E, Severini A.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00269-16. doi: 10.1128/CVI.00269-16. Print 2017 Jan.

22.

Effectiveness of pertussis vaccination and duration of immunity.

Schwartz KL, Kwong JC, Deeks SL, Campitelli MA, Jamieson FB, Marchand-Austin A, Stukel TA, Rosella L, Daneman N, Bolotin S, Drews SJ, Rilkoff H, Crowcroft NS.

CMAJ. 2016 Nov 1;188(16):E399-E406. doi: 10.1503/cmaj.160193. Epub 2016 Sep 26.

23.

EPR spectroscopy solutions for assessment of decellularization of intrathoracic organs and tissues.

Gubareva EA, Kuevda EV, Dzhimak SS, Basov AA, Sotnichenko AS, Bolotin SN, Gilevich IV, Gumenyuk IS, Macchiarini P.

Dokl Biochem Biophys. 2016 Mar;467(1):113-6. doi: 10.1134/S1607672916020101. Epub 2016 May 20.

PMID:
27193712
24.

Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.

Wilson SE, Rosella LC, Wang J, Le Saux N, Crowcroft NS, Harris T, Bolotin S, Deeks SL.

PLoS One. 2016 May 11;11(5):e0154340. doi: 10.1371/journal.pone.0154340. eCollection 2016.

25.

Global travel patterns and risk of measles in Ontario and Quebec, Canada: 2007-2011.

Wilson SE, Khan K, Gilca V, Miniota J, Deeks SL, Lim G, Eckhardt R, Bolotin S, Crowcroft NS.

BMC Infect Dis. 2015 Aug 18;15:341. doi: 10.1186/s12879-015-1039-0.

26.

What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Bolotin S, Harvill ET, Crowcroft NS.

Pathog Dis. 2015 Nov;73(8):ftv057. doi: 10.1093/femspd/ftv057. Epub 2015 Aug 6. Review.

27.

Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity.

Bolotin S, Deeks SL, Marchand-Austin A, Rilkoff H, Dang V, Walton R, Hashim A, Farrell D, Crowcroft NS.

PLoS One. 2015 Jul 17;10(7):e0133209. doi: 10.1371/journal.pone.0133209. eCollection 2015.

28.

How and why researchers use the number needed to vaccinate to inform decision making--a systematic review.

Hashim A, Dang V, Bolotin S, Crowcroft NS.

Vaccine. 2015 Feb 4;33(6):753-8. doi: 10.1016/j.vaccine.2014.12.033. Epub 2014 Dec 25. Review.

29.

Increased incidence of tuberculosis in zimbabwe, in association with food insecurity, and economic collapse: an ecological analysis.

Burke SJ, Lass E, Thistle P, Katumbe L, Jetha A, Schwarz D, Bolotin S, Barker RD, Simor A, Silverman M.

PLoS One. 2014 Feb 5;9(2):e83387. doi: 10.1371/journal.pone.0083387. eCollection 2014.

30.

Highly active anti-retroviral therapy in the prevention of mother-to-child transmission of HIV in rural Zimbabwe during the socio-economic crisis.

Thistle P, Bolotin S, Lam E, Schwarz D, Pilon R, Ndawana B, Simor AE, Silverman M.

Med Confl Surviv. 2011 Jul-Sep;27(3):165-76.

PMID:
22320015
31.

A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period.

Bolotin S, Pebody R, White PJ, McMenamin J, Perera L, Nguyen-Van-Tam JS, Barlow T, Watson JM; UK Severe Influenza Surveillance System (USISS) Steering Group.

PLoS One. 2012;7(1):e30279. doi: 10.1371/journal.pone.0030279. Epub 2012 Jan 23.

32.

Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11.

Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, Bolotin S, Vipond I, Muir P, Guiver M, McMenamin J, Reynolds A, Moore C, Gunson R, Thompson C, Galiano M, Bermingham A, Ellis J, Zambon M.

Euro Surveill. 2011 Feb 3;16(5). pii: 19784. Erratum in: Euro Surveill. 2011;16(6): pii=19789.

33.

Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11.

Ellis J, Galiano M, Pebody R, Lackenby A, Thompson C, Bermingham A, McLean E, Zhao H, Bolotin S, Dar O, Watson JM, Zambon M.

Euro Surveill. 2011 Jan 6;16(1). pii: 19760.

34.

Genotypic characterization of tuberculosis transmission within Toronto's under-housed population, 1997-2008.

Adam HJ, Guthrie JL, Bolotin S, Alexander DC, Stuart R, Pyskir D, Brown EM, Rea E, Chedore P, Jamieson FB.

Int J Tuberc Lung Dis. 2010 Oct;14(10):1350-3.

PMID:
20843430
35.

The Ontario universal typing of tuberculosis (OUT-TB) surveillance program--what it means to you.

Bolotin S, Alexander DC, Guthrie JL, Drews SJ, Jamieson F.

Can Respir J. 2010 May-Jun;17(3):e51-4. Review.

36.

Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.

Bolotin S, Alexander DC, Chedore P, Drews SJ, Jamieson F.

J Antimicrob Chemother. 2009 Aug;64(2):263-6. doi: 10.1093/jac/dkp183. Epub 2009 Jun 11.

PMID:
19520719
37.

Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.

Eshaghi A, Bolotin S, Burton L, Low DE, Mazzulli T, Drews SJ.

J Clin Virol. 2009 Jun;45(2):142-5. doi: 10.1016/j.jcv.2009.04.010. Epub 2009 May 17.

PMID:
19451021
38.

Validation of the TaqMan Influenza A Detection Kit and a rapid automated total nucleic acid extraction method to detect influenza A virus in nasopharyngeal specimens.

Bolotin S, De Lima C, Choi KW, Lombos E, Burton L, Mazzulli T, Drews SJ.

Ann Clin Lab Sci. 2009 Spring;39(2):155-9.

PMID:
19429802
39.

Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates.

Bolotin S, Robertson AV, Eshaghi A, De Lima C, Lombos E, Chong-King E, Burton L, Mazzulli T, Drews SJ.

J Virol Methods. 2009 Jun;158(1-2):190-4. doi: 10.1016/j.jviromet.2009.01.016. Epub 2009 Jan 30.

PMID:
19428589
40.

Verification of the Combimatrix influenza detection assay for the detection of influenza A subtype during the 2007-2008 influenza season in Toronto, Canada.

Bolotin S, Lombos E, Yeung R, Eshaghi A, Blair J, Drews SJ.

Virol J. 2009 Mar 25;6:37. doi: 10.1186/1743-422X-6-37.

41.
42.

Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America.

Davidson RJ, Davis I, Willey BM, Rizg K, Bolotin S, Porter V, Polsky J, Daneman N, McGeer A, Yang P, Scolnik D, Rowsell R, Imas O, Silverman MS.

PLoS One. 2008 Jul 16;3(7):e2727. doi: 10.1371/journal.pone.0002727.

43.

On the origin of the treponematoses: a phylogenetic approach.

Harper KN, Ocampo PS, Steiner BM, George RW, Silverman MS, Bolotin S, Pillay A, Saunders NJ, Armelagos GJ.

PLoS Negl Trop Dis. 2008 Jan 15;2(1):e148. doi: 10.1371/journal.pntd.0000148.

44.

The two-component system sivS/R regulates virulence in Streptococcus iniae.

Bolotin S, Fuller JD, Bast DJ, de Azavedo JC.

FEMS Immunol Med Microbiol. 2007 Dec;51(3):547-54.

45.

Capsule expression regulated by a two-component signal transduction system in Streptococcus iniae.

Bolotin S, Fuller JD, Bast DJ, Beveridge TJ, de Azavedo JC.

FEMS Immunol Med Microbiol. 2007 Aug;50(3):366-74. Epub 2007 May 30.

46.

Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein.

Welstead GG, Hsu EC, Iorio C, Bolotin S, Richardson CD.

J Virol. 2004 Sep;78(18):9666-74.

47.

[Rationalization of calculations of nutritive value of food in laboratory control].

Bolotin SV.

Gig Sanit. 1992 Feb;(2):46-9. Russian. No abstract available.

PMID:
1427164
48.

[Study of food allergy in nonspecific ulcerative colitis].

Drozdov VN, Bolotin SM, Maksimova LV, Levitan MKh.

Sov Med. 1974 Mar;37(3):7-10. Russian. No abstract available.

PMID:
4408015
49.

[Certain problems of pathogenesis of nonspecific ulcerative colitis].

Levitan MKh, Marko OP, Kapuller LL, Drozdov VN, Bolotin SM.

Ter Arkh. 1973 Jul;45(7):66-70. Russian. No abstract available.

PMID:
4755071
50.

[Volume of circulating blood plasma and electrolytes in patients with nonspecific ulcerative colitis].

Brandina AM, Chernomordik AE, Levitan MKh, Bolotin SM, Brusilovskii MI.

Klin Med (Mosk). 1971 Oct;49(10):69-72. Russian. No abstract available.

PMID:
5133156

Supplemental Content

Loading ...
Support Center